TLGT Teligent Inc.

Teligent, Inc. to Hold Conference Call for Fourth Quarter and 2019 Full Year Financial Results on Wednesday April 8, 2020

Teligent, Inc. to Hold Conference Call for Fourth Quarter and 2019 Full Year Financial Results on Wednesday April 8, 2020

BUENA, N.J., April 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00 a.m. ET on Wednesday, April 8, 2020 to discuss the 4th quarter and 2019 full year financial results and business update.

The Company filed Form NT 10-K on March 30, 2020. As such, the 2019 Form 10-K filing deadline for Teligent as a non-accelerated filer has been extended to April 14, 2020.

The Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.

This call is available via webcast and can be accessed under News & Events in the Investor Relations section of Teligent, Inc.'s website at .

About Teligent, Inc.

Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website at .

Contact:

Damian Finio

Teligent, Inc.

(856) 336-9117

 

EN
03/04/2020

Underlying

TLGTTeligent Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teligent Inc.

 PRESS RELEASE
Free
TLGT TELIGENT INC.

Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provi...

Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update –Update on FDA Inspection of Buena Facility–Assessing New Growth Opportunities in Injectables–Conference Call to Be Held on August 16, 2021 at 8:30 am Eastern Standard Time –Dial in: (877) 407-0792 US Toll Free Number  (201) 689-8263 International Number  Confirmation Number: 13721972 BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a busi...

August 16, 2021 1 EN
 PRESS RELEASE
Free
TLGT TELIGENT INC.

Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financi...

Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021 BUENA, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference call at 8:30AM ET on Monday, August 16th, 2021 to discuss the second quarter ended June 30, 2021 financial results and business update. Conference Call InformationDate: Monday, August 16, 2021Time: 8:30 a.m. Eastern TimeDial-in numbers: Toll Free: 877-407-0792 International: 201-6...

August 11, 2021 1 EN
 PRESS RELEASE
Free
TLGT TELIGENT INC.

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders Scheduled to Reconvene on July 21, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 30, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today that its Annual Meeting of Stockholders, scheduled for June 18, 2021 and adjourned to June 30, 2021, was convened and adjourned without any business being conducted due to the fact that there were not sufficient votes to approve all of the proposals presented at t...

June 30, 2021 1 EN
 PRESS RELEASE
Free
TLGT TELIGENT INC.

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders Scheduled to Reconvene on June 30, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 18, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today that its Annual Meeting of Stockholders, scheduled for June 18, 2021, was convened and adjourned without any business being conducted due to the fact that there were not sufficient votes to approve all of the proposals presented at the Annual Meeting. The Company ...

June 18, 2021 1 EN
 PRESS RELEASE
Free
TLGT TELIGENT INC.

Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provid...

Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update –Continued Remediation Progress Being Made–Reiterating Prior Guidance of Informing FDA on Inspection Readiness During 3Q2021–Conference Call to Be Held on May 25, 2021 at 4:30 pm Eastern Standard Time –Dial in: (800) 708-4540 US Toll Free Number  (847) 619-6397 US Number  Confirmation Number: 50161966 BUENA, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the first quarter of 2021 and pr...

May 25, 2021 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch